anmelden
25 € WM-Startbonus + 5 € Torbonus für jeden deutschen Treffer*
SPI
19.954,36
PKT
-96,42
PKT
-0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.12.22 | Novartis Underweight | Barclays Capital | |
| 23.12.22 | Roche Overweight | Barclays Capital | |
| 21.12.22 | UBS Outperform | RBC Capital Markets | |
| 20.12.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 20.12.22 | UBS Sector Perform | RBC Capital Markets | |
| 20.12.22 | DocMorris Sell | UBS AG | |
| 19.12.22 | Nestlé Neutral | Credit Suisse Group | |
| 19.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 19.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 19.12.22 | Givaudan Sell | UBS AG | |
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 16.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Givaudan Hold | Deutsche Bank AG | |
| 15.12.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 14.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 14.12.22 | Novartis Neutral | UBS AG | |
| 14.12.22 | Roche Neutral | UBS AG | |
| 13.12.22 | Nestlé Neutral | Credit Suisse Group | |
| 13.12.22 | Givaudan Sell | UBS AG | |
| 12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
| 12.12.22 | Peach Property Group Kaufen | SRC Research GmbH | |
| 09.12.22 | DocMorris Add | Baader Bank | |
| 09.12.22 | Novartis Sell | Deutsche Bank AG | |
| 09.12.22 | DocMorris Buy | Warburg Research | |
| 09.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 09.12.22 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 09.12.22 | UBS Neutral | Credit Suisse Group | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 08.12.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.12.22 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 07.12.22 | Novartis Sell | Deutsche Bank AG | |
| 06.12.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 05.12.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 05.12.22 | Nestlé Market-Perform | Bernstein Research |